In people with type 2 diabetes mellitus (T2DM), this secretion is impaired, thus disrupting normal homeostasis and resulting in increases in blood glucose level[3]
Although you are less likely to have heard of it, a forthcoming medication in current clinical trials is called retatrutide and emerging data suggest it might be the most effective drug so far when it is released
A patient with BMI 35 or higher would also meet Tier 1 by BMI alone, which is simpler to document
For those practicing intermittent fasting, ColonBroom GLP-1 Booster can be taken during eating windows without breaking the fast
Morgan Stanley Research reported that the global GLP-1 market could reach $190 billion by 2035, with China and Brazil in particular seeing possible rapid expansion in uptake
About 140,400 obese patients in Massachusetts were prescribed medications such as Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data compiled by Real Chemistry, a health analytics firm